SCHEMBL6506733

SCHEMBL6506733

COc1cc2c(c(OC)c1)C(c1cc(Cl)cc(Cl)c1)N(C(=O)c1cccn1C)CC2

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRIN2C Q14957 3/20 0.47
MTNR1B P49286 1/20 0.44
TRPV1 Q8NER1 1/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
PDE4B Q07343 1/20 0.40
SLC6A4 P31645 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
FKBP1A P62942 5/20 0.39
PARP1 P09874 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13972692 1.00 GRIN2C (0.47) GRIN2CMTNR1BTRPV1KMT2AMEN1
SCHEMBL4416842 0.84 GRIN2C (0.43) GRIN2CMTNR1BTRPV1KMT2AMEN1
SCHEMBL4422268 0.84 GRIN2C (0.55) GRIN2CMTNR1BTRPV1KMT2AMEN1
SCHEMBL4423024 0.82 MTNR1B (0.48) GRIN2CMTNR1BTRPV1KMT2AMEN1
SCHEMBL4411776 0.80 NPC1 (0.53) GRIN2CMTNR1BKMT2AMEN1CA12
SCHEMBL4414956 0.80 GRIN2C (0.54) GRIN2CKMT2AMEN1CA12CA1
SCHEMBL4411732 0.79 GRIN2C (0.56) GRIN2CKMT2AMEN1CA12CA1
SCHEMBL4416795 0.79 GRIN2C (0.45) GRIN2CMTNR1BTRPV1KMT2AMEN1
SCHEMBL4416128 0.79 TRPV1 (0.46) GRIN2CMTNR1BTRPV1KMT2AMEN1
SCHEMBL4416993 0.79 GRIN2C (0.45) GRIN2CMTNR1BTRPV1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050070570-A1 Novel potassium channels modulators 4SC AG (DE) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070570-A1 Novel potassium channels modulators HCN4, KCNA4, KCNN4 GRIN2C 567/4885MTNR1B 569/4885TRPV1 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.